Sublobar Resection for Adenocarcinoma in Situ/Minimally Invasive Adenocarcinoma Diagnosed by Intraoperative Frozen Section (ECTOP-1019)
Phase 3
Recruiting
- Conditions
- Sublobar ResectionFrozen SectionLung Adenocarcinoma
- Interventions
- Procedure: Sublobar Resection
- Registration Number
- NCT06031181
- Lead Sponsor
- Fudan University
- Brief Summary
This is a clinical trial from Eastern Cooperative Thoracic Oncology Project (ECTOP), numbered as ECTOP-1019. The goal of this clinical trial is to confirm the therapeutic effect of sublobar resection for AIS/MIA diagnosed by intraoperative frozen section.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- RECRUITING
- Sex
- All
- Target Recruitment
- 390
Inclusion Criteria
- Patients who sign the informed consent form and are willing to complete the study according to the plan;
- Aged from 18 to 80 years old;
- ECOG equals 0 or 1;
- Not receiving lung cancer surgery before;
- Resectable peripheral cT1N0M0 tumors;
- Single lung nodules with ground-glass dominant or pure ground-glass on CT, or multiple lung nodules with the major lesion being the aforementioned nodules;
- Adenocarcinoma in Situ/Minimally Invasive Adenocarcinoma Diagnosed by Intraoperative Frozen Section
- Not receiving chemotherapy or radiotherapy before.
Exclusion Criteria
- Not cT1N0M0;
- Cannot be completely resected by sublobar resection;
- Invasive lung adenocarcinoma or not lung adenocarcinoma diagnosed cytologically or pathologically;
- Receiving lung cancer surgery before;
- Receiving radiotherapy or chemotherapy.
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- SINGLE_GROUP
- Arm && Interventions
Group Intervention Description Sublobar resection Sublobar Resection Sublobar resection is performed for Adenocarcinoma in Situ/Minimally Invasive Adenocarcinoma Diagnosed by Intraoperative Frozen Section
- Primary Outcome Measures
Name Time Method 5-year recurrence-free survival 5 years The event is defined as the tumor recurrence.
- Secondary Outcome Measures
Name Time Method 5-year overall survival 5 years The event is defined as the death due to any causes.
Trial Locations
- Locations (1)
Fudan University Cancer Center
🇨🇳Shanghai, Shanghai, China